Preview Mode Links will not work in preview mode

This Week in Cardiology

Jul 7, 2023

European HTN Guidelines, vitamin D, bempedoic acid, and leadless pacing, with some critical appraisal techniques thrown in, are the topics John Mandrola, MD, tackles in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. European Hypertension Guidelines

New ESH Hypertension Guidelines Aim for Simplified Message

- 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH)

II. Vitamin D

CV Benefit From Vitamin-D Caps Hinted in Huge D-Health Trial

- Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial

- Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials

III. Bempedoic Acid

'Striking' Benefit of Lipid Lowering in Primary Prevention

- Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients

- Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease

- Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

IV. Leadless Pacing

FDA Approves First Leadless Dual-Chamber Pacing System

- A Dual-Chamber Leadless Pacemaker

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact